Back to Search
Start Over
BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma.
- Source :
-
British journal of haematology [Br J Haematol] 2017 Nov; Vol. 179 (4), pp. 684-688. Date of Electronic Publication: 2016 Jul 29. - Publication Year :
- 2017
- Subjects :
- Antineoplastic Agents therapeutic use
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Humans
Melanoma diagnosis
Melanoma drug therapy
Sulfonamides therapeutic use
Antineoplastic Agents pharmacology
Biomarkers, Tumor
Bridged Bicyclo Compounds, Heterocyclic pharmacology
Drug Resistance, Neoplasm genetics
Gene Expression Profiling
Melanoma genetics
Molecular Mimicry
Protein Interaction Domains and Motifs
Sulfonamides pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 179
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Report
- Accession number :
- 27471002
- Full Text :
- https://doi.org/10.1111/bjh.14251